Home › Depression › New Jersey › Toms River
Depression clinical trials in Toms River, NJ
5 studies for Depression are looking for participants at sites in and around Toms River (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RecruitingPhase 3
- Bio Behavioral Health, Toms River
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
RecruitingPhase 3
- Bio Behavioral Health, Toms River
E-Mindfulness Approaches for Living After Breast Cancer
RecruitingPhase 3
- Southern Ocean County Medical Center, Manahawkin · 18 mi away
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
RecruitingPhase 2
- Bio Behavioral Health, Toms River
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
RecruitingPhase 4
- Clinical Research Site, Toms River
About Depression
Depression is a serious medical illness. It affects almost 7 percent of U.S. adults. It causes feelings of sadness, hopelessness, and frustration that do not go away. Learn about treatments.
More about Depression on MedlinePlus
Depression trials in other cities
- Boston, MA52 studies
- New York City, NY45 studies
- Philadelphia, PA26 studies
- Atlanta, GA24 studies
- Chicago, IL24 studies
- Pittsburgh, PA22 studies
- San Diego, CA21 studies
- Charleston, SC19 studies
- Houston, TX18 studies
- Orlando, FL17 studies
- Los Angeles, CA17 studies
- Miami, FL16 studies
Other studies in Toms River
- Alzheimer's Disease9 studies
- Major Depressive Disorder6 studies
- Acute Myeloid Leukemia5 studies
- Breast Cancer4 studies
- Mental Disorders4 studies
- Colon Cancer3 studies
- Lung Cancer3 studies
- Dementia3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.